Cardiovascular disease (CVD) is a major cause of death in patients with chronic kidney
disease (CKD). Both conditions are rising in incidence as well as prevalence, creating poor …

Medial vascular calcification has emerged as a putative key factor contributing to the
excessive cardiovascular mortality of patients with chronic kidney disease (CKD) …

Osteoporosis is defined as a skeletal disorder of compromised bone strength predisposing
those affected to an elevated risk of fracture. However, based on bone histology …

Importance Among patients with hyperphosphatemia undergoing dialysis, it is unclear
whether non–calcium-based phosphate binders are more effective than calcium-based …

Hyperphosphatemia is a common complication in patients with chronic kidney disease
(CKD), particularly in those requiring renal replacement therapy. The importance of …

Interventions To Attenuate Vascular Calcification Progressio... : Journal of the American
Society of Nephrology Interventions To Attenuate Vascular Calcification Progression in Chronic …

Background Hyperphosphatemia is associated with cardiovascular morbidity and mortality
in patients receiving maintenance dialysis. It is unknown whether combining two therapies …

Hyperphosphatemia or even serum phosphate levels within the “normal laboratory range”
are highly associated with increased cardiovascular disease risk and mortality in the general …

Chronic kidney disease (CKD) is one of the most powerful predictors of premature
cardiovascular disease (CVD), with heightened susceptibility to vascular intimal and medial …

Background Secondary hyperparathyroidism (sHPT) develops frequently in patients with
chronic kidney disease (CKD). However, the burden and long-term impact of sHPT on the …